Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEAN FREDERICK COLOMBEL

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1356783989
CMS profile
198004
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$228,579.53

105 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $127,885.94 29
ABBVIE INC. $43,733.83 32
Janssen Scientific Affairs, LLC $11,162.99 8
Eli Lilly and Company $7,706.38 6
Merck Sharp & Dohme LLC $7,216.10 7
Celltrion, Inc. $5,125.00 2
Janssen Biotech, Inc. $4,909.37 6
SANOFI US SERVICES INC. $4,740.00 1
GENZYME CORPORATION $4,602.02 3
PFIZER INC. $4,500.00 1
Celltrion USA Inc. $3,225.00 4
F. Hoffmann-La Roche AG $2,833.76 2
Amgen Inc. $858.00 1
Lilly USA, LLC $54.71 2
Celgene Corporation $26.43 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

105 matching records · $228,579.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 105 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 105.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $2,600.0012/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133059 CMS
Janssen Biotech, Inc. $2,125.0012/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078441509 CMS
Takeda Pharmaceuticals U.S.A., Inc. $52.0712/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517108 CMS
Takeda Pharmaceuticals U.S.A., Inc. $318.5512/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517112 CMS
Takeda Pharmaceuticals U.S.A., Inc. $623.3312/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517116 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,333.6912/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517120 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13,560.0012/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517124 CMS
ABBVIE INC. $7,800.0012/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133057 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.2612/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517104 CMS
Janssen Biotech, Inc. $38.4212/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078450741 CMS
SANOFI US SERVICES INC. $4,740.0011/25/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139954468 CMS
ABBVIE INC. $4,200.0011/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133055 CMS
ABBVIE INC. $107.9511/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104181656 CMS
Eli Lilly and Company $2,500.0011/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135035498 CMS
Eli Lilly and Company $3,750.0011/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135056210 CMS
Lilly USA, LLC $23.0011/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135056306 CMS
Amgen Inc. $858.0011/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117530132 CMS
Eli Lilly and Company $55.0011/01/2024 Education No dispute reported Delay: No
Change: NEW
06/30/20261155179811 CMS
ABBVIE INC. $700.0010/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133053 CMS
ABBVIE INC. $350.0010/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133051 CMS
ABBVIE INC. $6.2810/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103492993 CMS
F. Hoffmann-La Roche AG $2,817.5010/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133028744 CMS
F. Hoffmann-La Roche AG $16.2610/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133028748 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,887.5010/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517100 CMS
ABBVIE INC. $1,400.0010/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133049 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.0010/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517096 CMS
ABBVIE INC. $2,100.0009/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133047 CMS
ABBVIE INC. $15,762.5008/28/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133045 CMS
Celgene Corporation $26.4308/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101176572 CMS
GENZYME CORPORATION $4,503.0008/12/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261155228090 CMS
GENZYME CORPORATION $31.0208/12/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155228092 CMS
GENZYME CORPORATION $68.0008/12/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155228094 CMS
ABBVIE INC. $700.0008/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103133043 CMS
Lilly USA, LLC $31.7108/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135034920 CMS
ABBVIE INC. $32.9307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103492991 CMS
Celltrion, Inc. $1,800.0007/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261112835754 CMS
Celltrion, Inc. $3,325.0007/15/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261112835755 CMS
PFIZER INC. $4,500.0006/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131918059 CMS
Takeda Pharmaceuticals U.S.A., Inc. $170.2806/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517077 CMS
Takeda Pharmaceuticals U.S.A., Inc. $257.4106/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517081 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,684.7306/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517084 CMS
Takeda Pharmaceuticals U.S.A., Inc. $92.9206/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517088 CMS
Takeda Pharmaceuticals U.S.A., Inc. $240.8606/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517092 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.8006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517069 CMS
Takeda Pharmaceuticals U.S.A., Inc. $45.4106/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517073 CMS
Takeda Pharmaceuticals U.S.A., Inc. $54.0606/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517061 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5.4006/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137517065 CMS
Janssen Biotech, Inc. $30.6706/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078444089 CMS
Celltrion USA Inc. $2,400.0005/31/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261075850107 CMS
Janssen Biotech, Inc. $2,550.0005/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078457813 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $104,954.37 68
PY2020 $75,452.09 36
PY2021 $40,164.51 26
PY2022 $119,765.28 66
PY2023 $113,539.44 68
PY2024 $228,579.53 105
PY2025 $103,239.37 79

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JEAN FREDERICK COLOMBEL, NPI 1356783989. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1356783989.
APA 7
IndustryPayments. (2026). JEAN FREDERICK COLOMBEL, NPI 1356783989 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1356783989
Bluebook
JEAN FREDERICK COLOMBEL, NPI 1356783989, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1356783989.

Source: Centers for Medicare & Medicaid Services, Open Payments.